Risk-based screening for Chlamydia trachomatis and Neisseria gonorrhoeae prior to intrauterine device insertion.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Contraception

• Publication date

  2014-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.contraception.2015.06.012PMID 26093189PMCID PMC4575889
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Long-Acting Reversible Contraception : Implants and Intrauterine Devices

  2017cited by this paper
• Sexually transmitted diseases treatment guidelines, 2015.

  2015cited by this paper
• Positive Testing for Neisseria gonorrhoeae and Chlamydia trachomatis and the Risk of Pelvic Inflammatory Disease in IUD Users

  2015cited by this paper
• U.S. Selected Practice Recommendations for Contraceptive Use, 2013: adapted from the World Health Organization selected practice recommendations for contraceptive use, 2nd edition.

  2013cited by this paper
• Sexually Transmitted Infection Prevalence in a Population Seeking No-Cost Contraception

  2013cited by this paper
• Prevalence of Neisseria gonorrhoeae Among Persons 14 to 39 Years of Age, United States, 1999 to 2008

  2013cited by this paper
• Prevention and control of seasonal influenza with vaccines. Recommendations of the Advisory Committee on Immunization Practices--United States, 2013-2014.

  2013cited by this paper
• Health Care Provider Attitudes and Practices Related to Intrauterine Devices for Nulliparous Women

  2012cited by this paper
• Neisseria gonorrhea and Chlamydia trachomatis Screening at Intrauterine Device Insertion and Pelvic Inflammatory Disease

  2012cited by this paper
• Chlamydia trachomatis Trends in the United States Among Persons 14 to 39 Years of Age, 1999–2008

  2012cited by this paper
• U S. Medical Eligibility Criteria for Contraceptive Use, 2010.

  2010cited by this paper
• A study investigating obstetricians’ and gynaecologists’ management of women requesting an intrauterine device

  2010cited by this paper
• Intrauterine contraception in Saint Louis: a survey of obstetrician and gynecologists' knowledge and attitudes.

  2010influential reference
• The Contraceptive CHOICE Project: reducing barriers to long-acting reversible contraception.

  2010cited by this paper
• U S. medical eligibility criteria for contraceptive use, 2010 : adapted from the World Health Organization Medical Eligibility Criteria for Contraceptive Use, 4th edition

  2010cited by this paper
• Sexually transmitted diseases treatment guidelines, 2010.

  2010cited by this paper
• Identifying appropriate IUD candidates in areas with high prevalence of sexually transmitted infections.

  2007cited by this paper
• Does insertion and use of an intrauterine device increase the risk of pelvic inflammatory disease among women with sexually transmitted infection? A systematic review.

  2006cited by this paper
• DEPARTMENT OF HEALTH AND HUMAN SERVICES PUBLIC HEALTH SERVICE CENTERS FOR DISEASE CONTROL AND PREVENTION NATIONAL CENTER FOR INJURY PREVENTION AND CONTROL ADVISORY COMMITTEE FOR INJURY PREVENTION AND CONTROL

  2006cited by this paper
• Vaginal Swabs Are the Specimens of Choice When Screening for Chlamydia trachomatis and Neisseria gonorrhoeae: Results From a Multicenter Evaluation of the APTIMA Assays for Both Infections

  2005cited by this paper
• Vaginal Swabs Are Appropriate Specimens for Diagnosis of Genital Tract Infection with Chlamydia trachomatis

  2003cited by this paper
• Obstetrician‐Gynecologists and the Intrauterine Device: A Survey of Attitudes and Practice

  2002cited by this paper
• Selected practice recommendations for contraceptive use

  2002cited by this paper
• Use of sexually transmitted disease risk assessment algorithms for selection of intrauterine device candidates.

  1999cited by this paper
• Intrauterine devices and pelvic inflammatory disease: An international perspective

  1992cited by this paper
• Sexually transmitted disease surveillance.

  1982cited by this paper

• SOP Intrauterine Kontrazeption

  2025cites this paper
• The Impact of Intrauterine Devices on the Risk of Ureaplasma Species Overgrowth: A Review of the Literature

  2025cites this paper
• Einlage eines Intrauterinsystems (IUS) – Schritt für Schritt

  2025cites this paper
• Spontaneous Clearance of Chlamydia trachomatis and Its Associated Factors among Women Attending Screening for Chlamydia in Shenzhen, China.

  2024cites this paper
• Cost-effectiveness analysis of levonorgestrel-releasing intrauterine system (LNG-IUS) 52 mg versus other long-acting reversible contraceptives for contraception in Spain

  2024cites this paper
• Highly‐Specific Single‐Stranded Oligonucleotides and Functional Nanoprobes for Clinical Determination of Chlamydia Trachomatis and Neisseria Gonorrhoeae Infections

  2023cites this paper
• Models of care for intrauterine device provision in Australian general practice.

  2023cites this paper
• Contraception Selection, Effectiveness, and Adverse Effects: A Review.

  2021cites this paper
• Screening for Chlamydial and Gonococcal Infections: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.

  2021cites this paper
• 2020 European guideline for the diagnosis and treatment of gonorrhoea in adults.

  2020cites this paper
• Risk-based screening to identify reproductive tract infection among HIV-infected women desiring use of intrauterine contraceptives

  2020cites this paper
• Background review for the ‘2020 European guideline for the diagnosis and treatment of gonorrhoea in adults’

  2020cites this paper
• Biofilm in Genital Ecosystem: A Potential Risk Factor for Chlamydia trachomatis Infection

  2019cites this paper
• Clinical practice guidelines for contraception of the French National College of Gynecologists and Obstetricians (CNGOF).

  2019cites this paper
• Republication de : Contraception : Recommandations pour la Pratique Clinique du CNGOF (texte court)

  2019cites this paper
• [Intrauterine contraception: CNGOF Contraception Guidelines].

  2018cites this paper
• Contraception : Recommandations pour la Pratique Clinique du CNGOF (texte court)

  2018cites this paper
• [Contraception: CNGOF Guidelines for Clinical Practice (Short Version)].

  2018cites this paper
• Updates From the Literature, January/February 2018.

  2018cites this paper
• The safety of available and emerging options for emergency contraception

  2017cites this paper
• Updates From the Literature, January/February 2017.

  2017cites this paper
• Long-Acting Reversible Contraception : Implants and Intrauterine Devices

  2017cites this paper
• Long-Acting Reversible Contraception: Implants and Intrauterine Devices

  2017cites this paper
• The safety of intrauterine contraception initiation among women with current asymptomatic cervical infections or at increased risk of sexually transmitted infections.

  2016influential citation
• Eliminating health disparities in unintended pregnancy with long-acting reversible contraception (LARC).

  2016cites this paper